We are live on
!
Find out more
IHM
Iguana Healthcare Management Portfolio holdings
AUM
$152M
1-Year Est. Return
48.74%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$246M
AUM Growth
-$27.1M
(-9.9%)
Cap. Flow
-$37.7M
Cap. Flow
% of AUM
-15.33%
Top 10 Holdings %
Top 10 Hldgs %
36.95%
Holding
116
New
41
Increased
15
Reduced
17
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$10.8M |
| 2 |
Elevance Health
ELV
|
+$9.58M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$7.09M |
| 4 |
Gilead Sciences
GILD
|
+$4.44M |
| 5 |
Illumina
ILMN
|
+$3.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
+$14.5M |
| 2 |
Cigna
CI
|
+$13.2M |
| 3 |
Medtronic
MDT
|
+$7.5M |
| 4 |
Baxter International
BAX
|
+$6.8M |
| 5 |
Eli Lilly
LLY
|
+$5.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 78.04% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $12.3M | 5.02% |
125,000
-50,000
| -29% | -$5.17M |
|
2
Zimmer Biomet
ZBH
$18.2B
| $12M | 4.9% |
103,000
+15,450
| +18% | +$1.75M |
|
|
3
Gilead Sciences
GILD
$162B
| $11.3M | 4.58% |
135,000
+50,000
| +59% | +$4.44M |
|
|
SHPG
4
DELISTED
Shire pic
SHPG
| $11M | 4.49% |
+60,000
| New | +$10.8M |
|
|
5
Elevance Health
ELV
$81.5B
| $9.19M | 3.74% |
+70,000
| New | +$9.58M |
|
|
OMED
6
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $7.78M | 3.17% |
632,200
+165,175
| +35% | +$2M |
|
7
Merck
MRK
$322B
| $7.2M | 2.93% |
131,000
-26,200
| -17% | -$1.39M |
|
8
Pfizer
PFE
$143B
| $7.04M | 2.86% |
210,800
| – | – |
|
9
Ultragenyx Pharmaceutical
RARE
$2.45B
| $6.85M | 2.79% |
140,000
+20,000
| +17% | +$1.29M |
|
|
10
Baxter International
BAX
$13.5B
| $6.11M | 2.48% |
135,000
-155,000
| -53% | -$6.8M |
|
|
NUVA
11
DELISTED
NuVasive, Inc.
NUVA
| $5.97M | 2.43% |
100,000
| – | – |
|
|
ALXN
12
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.84M | 2.37% |
+50,000
| New | +$7.09M |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.84M | 2.37% |
+50,000
| New | +$7.09M |
|
14
Biogen
BIIB
$30B
| $5.44M | 2.21% |
22,500
-7,500
| -25% | -$1.98M |
|
15
Amgen
AMGN
$208B
| $5.33M | 2.17% |
35,000
| – | – |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.98M | 2.02% |
300,000
+50,000
| +20% | +$1.01M |
|
|
MDCO
17
CALL
DELISTED
Medicines Co
MDCO
| $4.71M | 1.92% |
+140,000
| New | +$4.94M |
|
18
Supernus Pharmaceuticals
SUPN
$2.59B
| $4.58M | 1.86% |
225,000
-50,000
| -18% | -$887K |
|
|
DERM
19
DELISTED
Dermira, Inc.
DERM
| $4.39M | 1.79% |
150,000
+75,000
| +100% | +$2.07M |
|
20
Tenet Healthcare
THC
$20.5B
| $4.15M | 1.69% |
150,000
-25,000
| -14% | -$739K |
|
21
Glaukos
GKOS
$9.83B
| $3.94M | 1.6% |
135,000
+10,000
| +8% | +$231K |
|
|
22
PUT
Eli Lilly
LLY
$1.02T
| $3.91M | 1.59% |
+50,000
| New | +$3.76M |
|
23
HCA Healthcare
HCA
$87.2B
| $3.85M | 1.57% |
50,000
-50,000
| -50% | -$3.95M |
|
|
MZOR
24
DELISTED
Mazor Robotics Ltd.
MZOR
| $3.6M | 1.46% |
200,000
+75,000
| +60% | +$1.05M |
|
|
25
Illumina
ILMN
$31B
| $3.51M | 1.43% |
+25,700
| New | +$3.65M |
|
Similar funds
HWP
PAM
USG2
LCM
FPF
FIAS
CII
OPWM
Iguana Healthcare Management's Q2 2016 Portfolio in Review
As of Q2 2016, Iguana Healthcare Management held 116 positions worth $246M, down 9.9% from $273M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Iguana Healthcare Management withdrew a net $37.7M in Q2 2016, closing 34 positions and reducing 17 holdings. Its most notable exit was Cigna, an estimated $13.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 68% a quarter earlier, followed by Industrials.
Against the trend, Iguana Healthcare Management opened a new position in Shire pic worth $11M.
- Iguana Healthcare Management's largest Q2 2016 buy was Shire pic: 60,000 shares worth $11M.
- Iguana Healthcare Management added most to Gilead Sciences in Q2 2016, an estimated $4.44M increase.
- Iguana Healthcare Management's biggest Q2 2016 reduction was MEDIVATION, INC., cutting an estimated $14.5M.
- Iguana Healthcare Management fully exited Cigna in Q2 2016, selling an estimated $13.2M.
- Iguana Healthcare Management's ten largest holdings make up 37% of its $246M portfolio in Q2 2016.
- Iguana Healthcare Management opened 41 new positions and closed 34 in Q2 2016.
- Iguana Healthcare Management's portfolio value fell 9.9% quarter-over-quarter to $246M.
Based on Iguana Healthcare Management's 13F filing for Q2 2016, filed 15 Aug 2016.